Replies to post #58327 on Genta, Inc (fka GNTAQ)

[STOCK_GAINER6]

Compared to GFV LLC, which have already taken a valid patent for the tesetaxel synthesis, Genta is behind. But this isn't an issue, because it's the priority date, which counts always first, when a patent was applied for.